SCHEMBL4551650

SCHEMBL4551650

Cc1ncc(Nc2cc(F)cc(N3CCCCC3)c2)cc1C(=O)Nc1ccc(N(C)C2CCOCC2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 3/20 0.40
MAPK7 Q13164 1/20 0.39
SETD2 Q9BYW2 1/20 0.39
MAPK14 Q16539 2/20 0.38
LCK P06239 1/20 0.38
KDR P35968 1/20 0.38
TEK Q02763 1/20 0.38
PDE7A Q13946 2/20 0.37
DGAT1 O75907 1/20 0.37
PLAU P00749 1/20 0.37
RAF1 P04049 1/20 0.37
BRAF P15056 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5490933 0.99 PDE4B (0.41) PDE4BNPC1RAB9AMAPTMAPK7
SCHEMBL4551561 0.90 RAB9A (0.38) PDE4BNPC1RAB9AMAPTMAPK7
SCHEMBL4551789 0.90 PDE4B (0.37) PDE4BNPC1RAB9AMAPTMAPK7
SCHEMBL4551611 0.87 CSF1R (0.43) PDE4BMAPTMAPK14LCKKDR
SCHEMBL5487365 0.86 MAPK14 (0.46) PDE4BMAPK14RAF1BRAF
SCHEMBL4551536 0.86 SMN1; SMN2 (0.33) PDE4BMAPTMAPK7SETD2MAPK14
SCHEMBL4551772 0.85 PDE4B (0.43) PDE4BNPC1RAB9AMAPTMAPK14
SCHEMBL4551481 0.85 SETD2 (0.34) PDE4BMAPTMAPK7SETD2MAPK14
SCHEMBL4552137 0.81 KCNQ3 (0.46) NPC1RAB9AMAPTSETD2MAPK14
SCHEMBL4551615 0.81 PDE4B (0.45) PDE4BRAB9AMAPTMAPK14DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007056016-A2 BISAMIDE CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-05-18 WO disclosed